4.8 Review

Polyglutamine toxicity in non-neuronal cells

Journal

CELL RESEARCH
Volume 20, Issue 4, Pages 400-407

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/cr.2010.32

Keywords

polyglutamine; Huntington's disease; neurodegeneration; glia; misfolding; aggregation

Categories

Funding

  1. NIH [NS036232, AG019206, NS041669, AG031153]

Ask authors/readers for more resources

The neurodegenerative polyglutamine diseases are caused by an expansion of unstable polyglutamine repeats in various disease proteins. Although these mutant proteins are expressed ubiquitously in neuronal and non-neuronal cells, they cause selective degeneration of specific neuronal populations. Recently, increasing evidence shows that polyglutamine disease proteins also affect non-neuronal cells. However, it remains unclear how the expression of polyglutamine proteins in non-neuronal cells contributes to the course of the polyglutamine diseases. Here, we discuss recent findings about the expression of mutant polyglutamine proteins in non-neuronal cells and their influence on neurological symptoms. Understanding the contribution of non-neuronal polyglutamine proteins to disease progression will help elucidate disease mechanisms and also help in the development of new treatment options.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available